Stock listing

NAMS Stock Price, News, Filings & Events — Newamsterdam Pharma Company N.v.

Selected listing: NAMS · BOATS · USD · US

This page tracks Newamsterdam Pharma Company N.v.'s NAMS:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following NAMS:BOATS. NAMS:BOATS is the stock-level entry point for investors researching Newamsterdam Pharma Company N.v., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Newamsterdam Pharma Company N.V. is a publicly traded company listed under the ticker NAMS in the American market. With a market capitalization of approximately $3.7 billion, the company focuses on developing innovative pharmaceutical solutions. Their commitment to advancing healthcare is reflected in their ongoing research and development efforts.

NAMS:BOATSUSDUSUpdated August 7, 2026
Newamsterdam Pharma Company N.v. logo
Ticker
NAMS:BOATS
Asset type
Stock
Market cap
$3.34B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
BOATS
Currency
USD

Newamsterdam Pharma Company N.v. NAMS:BOATS stock context

This page tracks Newamsterdam Pharma Company N.v.'s NAMS:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following NAMS:BOATS. NAMS:BOATS is the stock-level entry point for investors researching Newamsterdam Pharma Company N.v., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Newamsterdam Pharma Company N.V. is a publicly traded company listed under the ticker NAMS in the American market. With a market capitalization of approximately $3.7 billion, the company focuses on developing innovative pharmaceutical solutions. Their commitment to advancing healthcare is reflected in their ongoing research and development efforts.

Latest news from Newamsterdam Pharma Company N.v.

All Newamsterdam Pharma Company N.v. news →

Newamsterdam Pharma Company N.v. earnings calls

Research Newamsterdam Pharma Company N.v.

Alternate listings